Literature DB >> 15153633

Transfection of the human malaria parasite Plasmodium falciparum.

Brendan S Crabb1, Melanie Rug, Tim-Wolf Gilberger, Jennifer K Thompson, Tony Triglia, Alexander G Maier, Alan F Cowman.   

Abstract

Methods to transiently and stably transfect blood stages of the human malaria parasite Plasmodium falciparum have been developed and adapted for gene-knockout, allelic replacement, and transgene expression in this organism. These methods are detailed in this chapter, as are approaches used to monitor transfectants during the selection process. The different plasmid vectors that are currently used for gene targeting and transgene expression (including green fluorescent protein expression) are also described.

Entities:  

Mesh:

Year:  2004        PMID: 15153633     DOI: 10.1385/1-59259-793-9:263

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  79 in total

1.  PFE0565w, a Plasmodium falciparum protein expressed in salivary gland sporozoites.

Authors:  Maggie S Schlarman; Renee N Roberts; Michael M Kariuki; Alexis N LaCrue; Ruguang Ou; Brenda T Beerntsen
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  Altered plasmodial surface anion channel activity and in vitro resistance to permeating antimalarial compounds.

Authors:  Godfrey Lisk; Margaret Pain; Morgan Sellers; Philip A Gurnev; Ajay D Pillai; Sergey M Bezrukov; Sanjay A Desai
Journal:  Biochim Biophys Acta       Date:  2010-05-06

3.  Malaria parasite tyrosyl-tRNA synthetase secretion triggers pro-inflammatory responses.

Authors:  Tarun Kumar Bhatt; Sameena Khan; Ved Prakash Dwivedi; Mudassir Meraj Banday; Arvind Sharma; Anmol Chandele; Noelia Camacho; Lluís Ribas de Pouplana; Yang Wu; Alister G Craig; Antti Tapani Mikkonen; Alexander Gerd Maier; Manickam Yogavel; Amit Sharma
Journal:  Nat Commun       Date:  2011-11-08       Impact factor: 14.919

4.  Trafficking of STEVOR to the Maurer's clefts in Plasmodium falciparum-infected erythrocytes.

Authors:  Jude M Przyborski; Susanne K Miller; Judith M Pfahler; Philipp P Henrich; Petra Rohrbach; Brendan S Crabb; Michael Lanzer
Journal:  EMBO J       Date:  2005-06-16       Impact factor: 11.598

5.  A set of glycosylphosphatidyl inositol-anchored membrane proteins of Plasmodium falciparum is refractory to genetic deletion.

Authors:  Paul R Sanders; Lev M Kats; Damien R Drew; Rebecca A O'Donnell; Matthew O'Neill; Alexander G Maier; Ross L Coppel; Brendan S Crabb
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  Tetracycline analogue-regulated transgene expression in Plasmodium falciparum blood stages using Toxoplasma gondii transactivators.

Authors:  Markus Meissner; Efrosinia Krejany; Paul R Gilson; Tania F de Koning-Ward; Dominique Soldati; Brendan S Crabb
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

7.  Development and host cell modifications of Plasmodium falciparum blood stages in four dimensions.

Authors:  Christof Grüring; Arlett Heiber; Florian Kruse; Johanna Ungefehr; Tim-Wolf Gilberger; Tobias Spielmann
Journal:  Nat Commun       Date:  2011-01-25       Impact factor: 14.919

8.  Biosynthesis of GDP-fucose and other sugar nucleotides in the blood stages of Plasmodium falciparum.

Authors:  Sílvia Sanz; Giulia Bandini; Diego Ospina; Maria Bernabeu; Karina Mariño; Carmen Fernández-Becerra; Luis Izquierdo
Journal:  J Biol Chem       Date:  2013-04-24       Impact factor: 5.157

9.  Structure, localization and histone binding properties of nuclear-associated nucleosome assembly protein from Plasmodium falciparum.

Authors:  Jasmita Gill; Anuj Kumar; Manickam Yogavel; Hassan Belrhali; S K Jain; Melanie Rug; Monica Brown; Alexander G Maier; Amit Sharma
Journal:  Malar J       Date:  2010-04-08       Impact factor: 2.979

10.  Plasmodium falciparum PfA-M1 aminopeptidase is trafficked via the parasitophorous vacuole and marginally delivered to the food vacuole.

Authors:  Omid Azimzadeh; Cissé Sow; Marc Gèze; Julius Nyalwidhe; Isabelle Florent
Journal:  Malar J       Date:  2010-06-30       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.